HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Experts discuss the current state of cancer clinical trials
• Should placebo-controlled trials be eliminated in favor of comparative-effectiveness research? Al B. Benson III, MD; Brian Rini, MD
• Flexible sigmoidoscopy reduced colorectal cancer incidence by one-third
• Future directions of lung cancer: Histology-based treatment, molecular markers Joseph Aisner, MD
• Increased microRNA in breast cancer cells linked to trastuzumab resistance
• Investor behavior once again prevents portfolio success Kenneth W. Rudzinski, CFP, CLU, ChFC, CRPC, CASL, CAP
• Panel members discuss IOM Cooperative Group recommendations
• Use of colorectal cancer screenings in the U.S. increased, but still underused
• Cross-fertilization of medical disciplines: An unfortunate victim of patent-madness and superspecialization Harry S. Jacob, MD, DHC
• Looking back: Lessons learned in fellowship William Wood, MD
• A direct, small scale approach to keep people from smoking Arthur Topilow, MD, FACP
• Adjuvant chemotherapy, radiotherapy feasible for resected gastric cancer
• Radiofrequency ablation may aid patients with bone metastasis pain
• Rituximab with infusional EPOCH effective in HIV-associated NHL
• Robot-assisted surgery acceptable for oropharyngeal tumor resection
• Roger J. Packer, MD: Upbringing influences his practice
• Blood test predicted need for treatment in men with prostate cancer
• Dietary vitamin K intake reduced risk for NHL
• ERCC1 expression associated with improved SCCHN survival with adjuvant therapy
• Obesity, smoking increased risk for prostate cancer–specific mortality
• Vitamin and calcium supplements reduced breast cancer risk
• VEGF signaling pathway inhibitors and hypertension: A review for oncologists Laura Boehnke Michaud, PharmD